Selected research
Industry Research
Fosfomycin Calcium Industry Research Report 2026
Market perspective
The global Fosfomycin Calcium market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fosfomycin Calcium is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fosfomycin Calcium is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fosfomycin Calcium include Shanghai Xinya Pharmaceutical, Shanghai Wuzhou Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shinpoong Pharm and Northeast Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fosfomycin Calcium market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fosfomycin Calcium Market by Company
Shanghai Xinya Pharmaceutical
Shanghai Wuzhou Pharmaceutical
Merck KGaA
Hubei Xunda Pharmaceutical
Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
Guangxi Nanning Baihui Pharmaceutical
Shanxi Dongjin Pharmaceutical Co., Ltd.
Shinpoong Pharm
Northeast Pharm
Manus Aktteva Biopharma LLP
FarmaSino Pharmaceutical
Ercros
Fosfomycin Calcium Segment by Type
Tablets
Injection
Fosfomycin Calcium Segment by Application
Medical
Microbiology
Others
Fosfomycin Calcium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Calcium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fosfomycin Calcium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fosfomycin Calcium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fosfomycin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Injection
Applications
- Medical
- Microbiology
- Others
Companies covered
- Shanghai Xinya Pharmaceutical
- Shanghai Wuzhou Pharmaceutical
- Merck KGaA
- Hubei Xunda Pharmaceutical
- Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- Guangxi Nanning Baihui Pharmaceutical
- Shanxi Dongjin Pharmaceutical Co., Ltd.
- Shinpoong Pharm
- Northeast Pharm
- Manus Aktteva Biopharma LLP
- FarmaSino Pharmaceutical
- Ercros
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fosfomycin Calcium Market Size (2021-2032)
- 2.2.2 Global Fosfomycin Calcium Sales (2021-2032)
- 2.2.3 Global Fosfomycin Calcium Market Average Price (2021-2032)
- 2.3 Fosfomycin Calcium by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Injection
- 2.4 Fosfomycin Calcium by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Microbiology
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fosfomycin Calcium Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fosfomycin Calcium Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Fosfomycin Calcium Revenue of Manufacturers (2021-2026)
- 3.4 Global Fosfomycin Calcium Average Price by Manufacturers (2021-2026)
- 3.5 Global Fosfomycin Calcium Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fosfomycin Calcium, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fosfomycin Calcium, Product Type & Application
- 3.8 Global Manufacturers of Fosfomycin Calcium, Established Date
- 3.9 Global Fosfomycin Calcium Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shanghai Xinya Pharmaceutical
- 4.1.1 Shanghai Xinya Pharmaceutical Company Information
- 4.1.2 Shanghai Xinya Pharmaceutical Business Overview
- 4.1.3 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Product Portfolio
- 4.1.5 Shanghai Xinya Pharmaceutical Recent Developments
- 4.2 Shanghai Wuzhou Pharmaceutical
- 4.2.1 Shanghai Wuzhou Pharmaceutical Company Information
- 4.2.2 Shanghai Wuzhou Pharmaceutical Business Overview
- 4.2.3 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Product Portfolio
- 4.2.5 Shanghai Wuzhou Pharmaceutical Recent Developments
- 4.3 Merck KGaA
- 4.3.1 Merck KGaA Company Information
- 4.3.2 Merck KGaA Business Overview
- 4.3.3 Merck KGaA Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck KGaA Fosfomycin Calcium Product Portfolio
- 4.3.5 Merck KGaA Recent Developments
- 4.4 Hubei Xunda Pharmaceutical
- 4.4.1 Hubei Xunda Pharmaceutical Company Information
- 4.4.2 Hubei Xunda Pharmaceutical Business Overview
- 4.4.3 Hubei Xunda Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hubei Xunda Pharmaceutical Fosfomycin Calcium Product Portfolio
- 4.4.5 Hubei Xunda Pharmaceutical Recent Developments
- 4.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
- 4.5.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
- 4.5.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Developments
- 4.6 Guangxi Nanning Baihui Pharmaceutical
- 4.6.1 Guangxi Nanning Baihui Pharmaceutical Company Information
- 4.6.2 Guangxi Nanning Baihui Pharmaceutical Business Overview
- 4.6.3 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Product Portfolio
- 4.6.5 Guangxi Nanning Baihui Pharmaceutical Recent Developments
- 4.7 Shanxi Dongjin Pharmaceutical Co., Ltd.
- 4.7.1 Shanxi Dongjin Pharmaceutical Co., Ltd. Company Information
- 4.7.2 Shanxi Dongjin Pharmaceutical Co., Ltd. Business Overview
- 4.7.3 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
- 4.7.5 Shanxi Dongjin Pharmaceutical Co., Ltd. Recent Developments
- 4.8 Shinpoong Pharm
- 4.8.1 Shinpoong Pharm Company Information
- 4.8.2 Shinpoong Pharm Business Overview
- 4.8.3 Shinpoong Pharm Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shinpoong Pharm Fosfomycin Calcium Product Portfolio
- 4.8.5 Shinpoong Pharm Recent Developments
- 4.9 Northeast Pharm
- 4.9.1 Northeast Pharm Company Information
- 4.9.2 Northeast Pharm Business Overview
- 4.9.3 Northeast Pharm Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Northeast Pharm Fosfomycin Calcium Product Portfolio
- 4.9.5 Northeast Pharm Recent Developments
- 4.10 Manus Aktteva Biopharma LLP
- 4.10.1 Manus Aktteva Biopharma LLP Company Information
- 4.10.2 Manus Aktteva Biopharma LLP Business Overview
- 4.10.3 Manus Aktteva Biopharma LLP Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Manus Aktteva Biopharma LLP Fosfomycin Calcium Product Portfolio
- 4.10.5 Manus Aktteva Biopharma LLP Recent Developments
- 4.11 FarmaSino Pharmaceutical
- 4.11.1 FarmaSino Pharmaceutical Company Information
- 4.11.2 FarmaSino Pharmaceutical Business Overview
- 4.11.3 FarmaSino Pharmaceutical Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 FarmaSino Pharmaceutical Fosfomycin Calcium Product Portfolio
- 4.11.5 FarmaSino Pharmaceutical Recent Developments
- 4.12 Ercros
- 4.12.1 Ercros Company Information
- 4.12.2 Ercros Business Overview
- 4.12.3 Ercros Fosfomycin Calcium Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ercros Fosfomycin Calcium Product Portfolio
- 4.12.5 Ercros Recent Developments
5 Global Fosfomycin Calcium Market Scenario by Region
- 5.1 Global Fosfomycin Calcium Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fosfomycin Calcium Sales by Region: 2021-2032
- 5.2.1 Global Fosfomycin Calcium Sales by Region: 2021-2026
- 5.2.2 Global Fosfomycin Calcium Sales by Region: 2027-2032
- 5.3 Global Fosfomycin Calcium Revenue by Region: 2021-2032
- 5.3.1 Global Fosfomycin Calcium Revenue by Region: 2021-2026
- 5.3.2 Global Fosfomycin Calcium Revenue by Region: 2027-2032
- 5.4 North America Fosfomycin Calcium Market Facts & Figures by Country
- 5.4.1 North America Fosfomycin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fosfomycin Calcium Sales by Country (2021-2032)
- 5.4.3 North America Fosfomycin Calcium Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fosfomycin Calcium Market Facts & Figures by Country
- 5.5.1 Europe Fosfomycin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fosfomycin Calcium Sales by Country (2021-2032)
- 5.5.3 Europe Fosfomycin Calcium Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fosfomycin Calcium Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fosfomycin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fosfomycin Calcium Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fosfomycin Calcium Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fosfomycin Calcium Market Facts & Figures by Country
- 5.7.1 South America Fosfomycin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fosfomycin Calcium Sales by Country (2021-2032)
- 5.7.3 South America Fosfomycin Calcium Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fosfomycin Calcium Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fosfomycin Calcium Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fosfomycin Calcium Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fosfomycin Calcium Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fosfomycin Calcium Sales by Type (2021-2032)
- 6.1.1 Global Fosfomycin Calcium Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Fosfomycin Calcium Sales Market Share by Type (2021-2032)
- 6.2 Global Fosfomycin Calcium Revenue by Type (2021-2032)
- 6.2.1 Global Fosfomycin Calcium Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fosfomycin Calcium Revenue Market Share by Type (2021-2032)
- 6.3 Global Fosfomycin Calcium Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fosfomycin Calcium Sales by Application (2021-2032)
- 7.1.1 Global Fosfomycin Calcium Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Fosfomycin Calcium Sales Market Share by Application (2021-2032)
- 7.2 Global Fosfomycin Calcium Revenue by Application (2021-2032)
- 7.2.1 Global Fosfomycin Calcium Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fosfomycin Calcium Revenue Market Share by Application (2021-2032)
- 7.3 Global Fosfomycin Calcium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fosfomycin Calcium Value Chain Analysis
- 8.1.1 Fosfomycin Calcium Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fosfomycin Calcium Production Mode & Process
- 8.2 Fosfomycin Calcium Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fosfomycin Calcium Distributors
- 8.2.3 Fosfomycin Calcium Customers
9 Global Fosfomycin Calcium Analyzing Market Dynamics
- 9.1 Fosfomycin Calcium Industry Trends
- 9.2 Fosfomycin Calcium Industry Drivers
- 9.3 Fosfomycin Calcium Industry Opportunities and Challenges
- 9.4 Fosfomycin Calcium Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst